Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Cross-species Analyses of Intra-species Behavioral Differences in Mammals and Fish.

Demin KA, Lakstygal AM, Volgin AD, de Abreu MS, Genario R, Alpyshov ET, Serikuly N, Wang D, Wang J, Yan D, Wang M, Yang L, Hu G, Bytov M, Zabegalov KA, Zhdanov A, Harvey BH, Costa F, Rosemberg DB, Leonard BE, Fontana BD, Cleal M, Parker MO, Wang J, Song C, Amstislavskaya TG, Kalueff AV.

Neuroscience. 2020 Jan 10. pii: S0306-4522(19)30890-5. doi: 10.1016/j.neuroscience.2019.12.035. [Epub ahead of print] Review.

PMID:
31931109
2.

Understanding neurobehavioral genetics of zebrafish.

Cheresiz SV, Volgin AD, Kokorina Evsyukova A, Bashirzade AAO, Demin KA, de Abreu MS, Amstislavskaya TG, Kalueff AV.

J Neurogenet. 2020 Jan 5:1-13. doi: 10.1080/01677063.2019.1698565. [Epub ahead of print]

PMID:
31902276
3.

Ultrasound stress compromises the correlates of emotional-like states and brain AMPAR expression in mice: effects of antioxidant and anti-inflammatory herbal treatment.

Costa-Nunes JP, Gorlova A, Pavlov D, Cespuglio R, Gorovaya A, Proshin A, Umriukhin A, Ponomarev ED, Kalueff AV, Strekalova T, Schroeter CA.

Stress. 2020 Jan 13:1-15. doi: 10.1080/10253890.2019.1709435. [Epub ahead of print]

PMID:
31900023
4.

A new method for vibration-based neurophenotyping of zebrafish.

Wang J, Wang D, Hu G, Yang L, Yan D, Wang M, Serikuly N, Alpyshov E, Amstislavskaya TG, Demin KA, de Abreu MS, Zabegalov KN, Kalueff AV.

J Neurosci Methods. 2019 Dec 18;333:108563. doi: 10.1016/j.jneumeth.2019.108563. [Epub ahead of print]

PMID:
31863804
5.

Seahorse treatment improves depression-like behavior in mice exposed to CUMS through reducing inflammation/oxidants and restoring neurotransmitter and neurotrophin function.

Li K, Yan L, Zhang Y, Yang Z, Zhang C, Li Y, Kalueff AV, Li W, Song C.

J Ethnopharmacol. 2020 Mar 25;250:112487. doi: 10.1016/j.jep.2019.112487. Epub 2019 Dec 17.

PMID:
31857128
6.

Prefrontal cortex inflammation and liver pathologies accompany cognitive and motor deficits following Western diet consumption in non-obese female mice.

Veniaminova E, Oplatchikova M, Bettendorff L, Kotenkova E, Lysko A, Vasilevskaya E, Kalueff AV, Fedulova L, Umriukhin A, Lesch KP, Anthony DC, Strekalova T.

Life Sci. 2020 Jan 15;241:117163. doi: 10.1016/j.lfs.2019.117163. Epub 2019 Dec 13.

PMID:
31837337
7.

Emotional behavior in aquatic organisms? Lessons from crayfish and zebrafish.

de Abreu MS, Maximino C, Banha F, Anastácio PM, Demin KA, Kalueff AV, Soares MC.

J Neurosci Res. 2019 Nov 12. doi: 10.1002/jnr.24550. [Epub ahead of print] Review.

PMID:
31722127
8.

Sex differences in adult zebrafish anxiolytic-like responses to diazepam and melatonin.

Genario R, Giacomini ACVV, de Abreu MS, Marcon L, Demin KA, Kalueff AV.

Neurosci Lett. 2020 Jan 1;714:134548. doi: 10.1016/j.neulet.2019.134548. Epub 2019 Oct 17.

PMID:
31629774
9.

Zebrafish as a Model of Neurodevelopmental Disorders.

de Abreu MS, Genario R, Giacomini ACVV, Demin KA, Lakstygal AM, Amstislavskaya TG, Fontana BD, Parker MO, Kalueff AV.

Neuroscience. 2019 Aug 29. pii: S0306-4522(19)30607-4. doi: 10.1016/j.neuroscience.2019.08.034. [Epub ahead of print]

PMID:
31472215
10.

High-glucose/high-cholesterol diet in zebrafish evokes diabetic and affective pathogenesis: The role of peripheral and central inflammation, microglia and apoptosis.

Wang J, Li Y, Lai K, Zhong Q, Demin KA, Kalueff AV, Song C.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109752. doi: 10.1016/j.pnpbp.2019.109752. Epub 2019 Aug 22.

PMID:
31446160
11.

Developing zebrafish experimental animal models relevant to schizophrenia.

Demin KA, Meshalkina DA, Volgin AD, Yakovlev OV, de Abreu MS, Alekseeva PA, Friend AJ, Lakstygal AM, Zabegalov K, Amstislavskaya TG, Strekalova T, Bao W, Kalueff AV.

Neurosci Biobehav Rev. 2019 Oct;105:126-133. doi: 10.1016/j.neubiorev.2019.07.017. Epub 2019 Jul 29. Review.

PMID:
31369798
12.

Naloxone prolongs abdominal constriction writhing-like behavior in a zebrafish-based pain model.

Costa FV, Canzian J, Stefanello FV, Kalueff AV, Rosemberg DB.

Neurosci Lett. 2019 Aug 24;708:134336. doi: 10.1016/j.neulet.2019.134336. Epub 2019 Jun 18.

PMID:
31220523
13.

Sex differences in behavior and neuropharmacology of zebrafish.

Genario R, de Abreu MS, Giacomini ACVV, Demin KA, Kalueff AV.

Eur J Neurosci. 2019 May 15. doi: 10.1111/ejn.14438. [Epub ahead of print] Review.

PMID:
31090957
14.

Abnormal repetitive behaviors in zebrafish and their relevance to human brain disorders.

Zabegalov KN, Khatsko SL, Lakstygal AM, Demin KA, Cleal M, Fontana BD, McBride SD, Harvey BH, de Abreu MS, Parker MO, Kalueff AV.

Behav Brain Res. 2019 Jul 23;367:101-110. doi: 10.1016/j.bbr.2019.03.044. Epub 2019 Mar 27. Review.

PMID:
30926483
15.

Modeling gut-brain interactions in zebrafish.

de Abreu MS, Giacomini ACVV, Sysoev M, Demin KA, Alekseeva PA, Spagnoli ST, Kalueff AV.

Brain Res Bull. 2019 May;148:55-62. doi: 10.1016/j.brainresbull.2019.03.003. Epub 2019 Mar 16. Review.

PMID:
30890360
16.

Pharmacological screening of a new alpha-2 adrenergic receptor agonist, mafedine, in zebrafish.

Sysoev YI, Meshalkina DA, Petrov DV, Okovityi SV, Musienko PE, Kalueff AV.

Neurosci Lett. 2019 May 14;701:234-239. doi: 10.1016/j.neulet.2019.03.001. Epub 2019 Mar 2.

PMID:
30836120
17.

The role of intraspecies variation in fish neurobehavioral and neuropharmacological phenotypes in aquatic models.

Demin KA, Lakstygal AM, Alekseeva PA, Sysoev M, de Abreu MS, Alpyshov ET, Serikuly N, Wang D, Wang M, Tang Z, Yan D, Strekalova TV, Volgin AD, Amstislavskaya TG, Wang J, Song C, Kalueff AV.

Aquat Toxicol. 2019 May;210:44-55. doi: 10.1016/j.aquatox.2019.02.015. Epub 2019 Feb 20. Review.

PMID:
30822702
18.

When fish take a bath: Psychopharmacological characterization of the effects of a synthetic cathinone bath salt 'flakka' on adult zebrafish.

Kolesnikova TO, Khatsko SL, Eltsov OS, Shevyrin VA, Kalueff AV.

Neurotoxicol Teratol. 2019 May - Jun;73:15-21. doi: 10.1016/j.ntt.2019.02.001. Epub 2019 Feb 20.

PMID:
30796953
19.

Animal models of major depressive disorder and the implications for drug discovery and development.

Demin KA, Sysoev M, Chernysh MV, Savva AK, Koshiba M, Wappler-Guzzetta EA, Song C, De Abreu MS, Leonard B, Parker MO, Harvey BH, Tian L, Vasar E, Strekalova T, Amstislavskaya TG, Volgin AD, Alpyshov ET, Wang D, Kalueff AV.

Expert Opin Drug Discov. 2019 Apr;14(4):365-378. doi: 10.1080/17460441.2019.1575360. Epub 2019 Feb 22.

PMID:
30793996
20.

Zebrafish models for attention deficit hyperactivity disorder (ADHD).

Fontana BD, Franscescon F, Rosemberg DB, Norton WHJ, Kalueff AV, Parker MO.

Neurosci Biobehav Rev. 2019 May;100:9-18. doi: 10.1016/j.neubiorev.2019.02.009. Epub 2019 Feb 16. Review.

PMID:
30779935
21.

Opioid Neurobiology, Neurogenetics and Neuropharmacology in Zebrafish.

Bao W, Volgin AD, Alpyshov ET, Friend AJ, Strekalova TV, de Abreu MS, Collins C, Amstislavskaya TG, Demin KA, Kalueff AV.

Neuroscience. 2019 Apr 15;404:218-232. doi: 10.1016/j.neuroscience.2019.01.045. Epub 2019 Jan 31. Review.

PMID:
30710667
22.

Neuropharmacology, pharmacogenetics and pharmacogenomics of aggression: The zebrafish model.

de Abreu MS, Giacomini ACVV, Genario R, Dos Santos BE, da Rosa LG, Demin KA, Wappler-Guzzetta EA, Kalueff AV.

Pharmacol Res. 2019 Mar;141:602-608. doi: 10.1016/j.phrs.2019.01.044. Epub 2019 Jan 29. Review.

PMID:
30708051
23.
24.

Astrocyte-Conditioned Medium Protects Prefrontal Cortical Neurons from Glutamate-Induced Cell Death by Inhibiting TNF-α Expression.

Song C, Wu YS, Yang ZY, Kalueff AV, Tsao YY, Dong Y, Su KP.

Neuroimmunomodulation. 2019;26(1):33-42. doi: 10.1159/000495211. Epub 2019 Jan 30.

PMID:
30699428
25.

DARK Classics in Chemical Neuroscience: Arecoline.

Volgin AD, Bashirzade A, Amstislavskaya TG, Yakovlev OA, Demin KA, Ho YJ, Wang D, Shevyrin VA, Yan D, Tang Z, Wang J, Wang M, Alpyshov ET, Serikuly N, Wappler-Guzzetta EA, Lakstygal AM, Kalueff AV.

ACS Chem Neurosci. 2019 May 15;10(5):2176-2185. doi: 10.1021/acschemneuro.8b00711. Epub 2019 Feb 21.

PMID:
30664352
26.

The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: Translational lessons from zebrafish.

Genario R, Giacomini ACVV, Demin KA, Dos Santos BE, Marchiori NI, Volgin AD, Bashirzade A, Amstislavskaya TG, de Abreu MS, Kalueff AV.

Neurosci Biobehav Rev. 2019 Apr;99:117-127. doi: 10.1016/j.neubiorev.2018.12.025. Epub 2019 Jan 3. Review.

PMID:
30611799
27.

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens.

Lakstygal AM, Kolesnikova TO, Khatsko SL, Zabegalov KN, Volgin AD, Demin KA, Shevyrin VA, Wappler-Guzzetta EA, Kalueff AV.

ACS Chem Neurosci. 2019 May 15;10(5):2144-2159. doi: 10.1021/acschemneuro.8b00615. Epub 2019 Jan 10.

PMID:
30566832
28.

Zebrafish models of diabetes-related CNS pathogenesis.

Lakstygal AM, de Abreu MS, Lifanov DA, Wappler-Guzzetta EA, Serikuly N, Alpsyshov ET, Wang D, Wang M, Tang Z, Yan D, Demin KA, Volgin AD, Amstislavskaya TG, Wang J, Song C, Alekseeva P, Kalueff AV.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:48-58. doi: 10.1016/j.pnpbp.2018.11.016. Epub 2018 Nov 23. Review.

PMID:
30476525
29.

Neuroinflammation and aberrant hippocampal plasticity in a mouse model of emotional stress evoked by exposure to ultrasound of alternating frequencies.

Pavlov D, Bettendorff L, Gorlova A, Olkhovik A, Kalueff AV, Ponomarev ED, Inozemtsev A, Chekhonin V, Lesсh KP, Anthony DC, Strekalova T.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 2;90:104-116. doi: 10.1016/j.pnpbp.2018.11.014. Epub 2018 Nov 22.

PMID:
30472146
30.

Understanding zebrafish aggressive behavior.

Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Friend AJ, Bao W, Alekseeva PA, Lakstygal AM, Meshalkina DA, Demin KA, de Abreu MS, Rosemberg DB, Kalueff AV.

Behav Processes. 2019 Jan;158:200-210. doi: 10.1016/j.beproc.2018.11.010. Epub 2018 Nov 20. Review.

PMID:
30468887
31.

Legal aspects of zebrafish neuropharmacology and neurotoxicology research.

de Abreu MS, Giacomini ACVV, Echevarria DJ, Kalueff AV.

Regul Toxicol Pharmacol. 2019 Feb;101:65-70. doi: 10.1016/j.yrtph.2018.11.007. Epub 2018 Nov 16. Review.

PMID:
30453007
32.

Effects of lidocaine on adult zebrafish behavior and brain acetylcholinesterase following peripheral and systemic administration.

de Abreu MS, Giacomini ACVV, Dos Santos BE, Genario R, Marchiori NI, Rosa LGD, Kalueff AV.

Neurosci Lett. 2019 Jan 23;692:181-186. doi: 10.1016/j.neulet.2018.11.004. Epub 2018 Nov 3.

PMID:
30399397
33.

DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka").

Kolesnikova TO, Khatsko SL, Demin KA, Shevyrin VA, Kalueff AV.

ACS Chem Neurosci. 2019 Jan 16;10(1):168-174. doi: 10.1021/acschemneuro.8b00525. Epub 2018 Nov 26.

PMID:
30384587
34.

Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish.

Volgin AD, Yakovlev OA, Demin KA, Alekseeva PA, Kalueff AV.

Behav Brain Res. 2019 Feb 1;359:274-280. doi: 10.1016/j.bbr.2018.10.033. Epub 2018 Oct 23.

PMID:
30366034
35.

Zebrafish models for personalized psychiatry: Insights from individual, strain and sex differences, and modeling gene x environment interactions.

Volgin AD, Yakovlev OA, Demin KA, de Abreu MS, Alekseeva PA, Friend AJ, Lakstygal AM, Amstislavskaya TG, Bao W, Song C, Kalueff AV.

J Neurosci Res. 2019 Apr;97(4):402-413. doi: 10.1002/jnr.24337. Epub 2018 Oct 15. Review.

PMID:
30320468
36.

Understanding nociception-related phenotypes in adult zebrafish: Behavioral and pharmacological characterization using a new acetic acid model.

Costa FV, Rosa LV, Quadros VA, Santos ARS, Kalueff AV, Rosemberg DB.

Behav Brain Res. 2019 Feb 1;359:570-578. doi: 10.1016/j.bbr.2018.10.009. Epub 2018 Oct 5.

PMID:
30296529
37.

Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models.

Volgin AD, Yakovlev OA, Demin KA, Alekseeva PA, Kyzar EJ, Collins C, Nichols DE, Kalueff AV.

ACS Chem Neurosci. 2019 Jan 16;10(1):143-154. doi: 10.1021/acschemneuro.8b00433. Epub 2018 Oct 16.

PMID:
30252437
38.

Zebrafish models of epigenetic regulation of CNS functions.

Lakstygal AM, de Abreu MS, Kalueff AV.

Brain Res Bull. 2018 Sep;142:344-351. doi: 10.1016/j.brainresbull.2018.08.022. Epub 2018 Sep 1. Review.

PMID:
30179679
39.

Understanding the Role of Environmental Enrichment in Zebrafish Neurobehavioral Models.

Volgin AD, Yakovlev OV, Demin KA, Abreu MS, Rosemberg DB, Meshalkina DA, Alekseeva PA, Friend AJ, Amstislavskaya TG, Kalueff AV.

Zebrafish. 2018 Oct;15(5):425-432. doi: 10.1089/zeb.2018.1592. Epub 2018 Aug 22.

PMID:
30133416
40.

The effects of auditory enrichment on zebrafish behavior and physiology.

Barcellos HHA, Koakoski G, Chaulet F, Kirsten KS, Kreutz LC, Kalueff AV, Barcellos LJG.

PeerJ. 2018 Jul 23;6:e5162. doi: 10.7717/peerj.5162. eCollection 2018.

41.

Zebrafish models: do we have valid paradigms for depression?

de Abreu MS, Friend AJ, Demin KA, Amstislavskaya TG, Bao W, Kalueff AV.

J Pharmacol Toxicol Methods. 2018 Nov - Dec;94(Pt 2):16-22. doi: 10.1016/j.vascn.2018.07.002. Epub 2018 Jul 18. Review.

PMID:
30030185
42.

Understanding taurine CNS activity using alternative zebrafish models.

Mezzomo NJ, Fontana BD, Kalueff AV, Barcellos LJG, Rosemberg DB.

Neurosci Biobehav Rev. 2018 Jul;90:471-485. doi: 10.1016/j.neubiorev.2018.04.012. Epub 2018 May 8.

PMID:
29747866
43.

The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry.

Meshalkina DA, Kysil EV, Antonova KA, Demin KA, Kolesnikova TO, Khatsko SL, Gainetdinov RR, Alekseeva PA, Kalueff AV.

Neurochem Res. 2018 Jun;43(6):1191-1199. doi: 10.1007/s11064-018-2536-5. Epub 2018 May 8.

PMID:
29740748
44.

Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.

de Abreu MS, Friend AJ, Amstislavskaya TG, Kalueff AV.

Front Pharmacol. 2018 Apr 3;9:293. doi: 10.3389/fphar.2018.00293. eCollection 2018. No abstract available.

45.

Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.

Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Alekseeva PA, Meshalkina DA, Friend AJ, Bao W, Demin KA, Gainetdinov RR, Kalueff AV.

Eur J Pharmacol. 2018 Jun 15;829:129-140. doi: 10.1016/j.ejphar.2018.04.003. Epub 2018 Apr 5. Review.

PMID:
29627310
46.

Psychoneuroimmunology and immunopsychiatry of zebrafish.

de Abreu MS, Giacomini ACVV, Zanandrea R, Dos Santos BE, Genario R, de Oliveira GG, Friend AJ, Amstislavskaya TG, Kalueff AV.

Psychoneuroendocrinology. 2018 Jun;92:1-12. doi: 10.1016/j.psyneuen.2018.03.014. Epub 2018 Mar 22. Review.

PMID:
29609110
47.

Zebrafish models relevant to studying central opioid and endocannabinoid systems.

Demin KA, Meshalkina DA, Kysil EV, Antonova KA, Volgin AD, Yakovlev OA, Alekseeva PA, Firuleva MM, Lakstygal AM, de Abreu MS, Barcellos LJG, Bao W, Friend AJ, Amstislavskaya TG, Rosemberg DB, Musienko PE, Song C, Kalueff AV.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:301-312. doi: 10.1016/j.pnpbp.2018.03.024. Epub 2018 Mar 28. Review.

PMID:
29604314
48.

Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy.

Kulikov AV, Gainetdinov RR, Ponimaskin E, Kalueff AV, Naumenko VS, Popova NK.

Expert Opin Ther Targets. 2018 Apr;22(4):319-330. doi: 10.1080/14728222.2018.1452912. Epub 2018 Apr 4. Review.

PMID:
29542343
49.

The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review.

Fontana BD, Mezzomo NJ, Kalueff AV, Rosemberg DB.

Exp Neurol. 2018 Jan;299(Pt A):157-171. doi: 10.1016/j.expneurol.2017.10.004. Epub 2017 Oct 5. Review.

PMID:
28987462
50.

Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling.

Meshalkina DA, Kysil EV, Warnick JE, Demin KA, Kalueff AV.

Lab Anim (NY). 2017 Oct 6;46(10):378-387. doi: 10.1038/laban.1345.

PMID:
28984854

Supplemental Content

Loading ...
Support Center